Galectin Therapeutics, Inc. (GALT)
3.90
+0.14
(+3.72%)
USD |
NASDAQ |
Oct 02, 16:00
3.85
-0.05
(-1.28%)
After-Hours: 20:00
Galectin Therapeutics Total Return Level : 3.90 for Oct. 2, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.90 |
| October 01, 2026 | 3.76 |
| September 30, 2026 | 3.88 |
| September 29, 2026 | 3.91 |
| September 28, 2026 | 3.93 |
| September 25, 2026 | 3.90 |
| September 24, 2026 | 3.96 |
| September 23, 2026 | 4.05 |
| September 22, 2026 | 4.14 |
| September 21, 2026 | 3.96 |
| September 18, 2026 | 3.89 |
| September 17, 2026 | 3.71 |
| September 16, 2026 | 3.68 |
| September 15, 2026 | 3.73 |
| September 14, 2026 | 3.84 |
| September 11, 2026 | 3.91 |
| September 10, 2026 | 3.90 |
| September 09, 2026 | 4.05 |
| September 08, 2026 | 4.14 |
| September 04, 2026 | 4.61 |
| September 03, 2026 | 4.35 |
| September 02, 2026 | 4.48 |
| September 01, 2026 | 4.17 |
| August 31, 2026 | 3.95 |
| August 28, 2026 | 4.02 |
| Date | Value |
|---|---|
| August 27, 2026 | 4.14 |
| August 26, 2026 | 4.15 |
| August 25, 2026 | 3.99 |
| August 24, 2026 | 3.88 |
| August 21, 2026 | 3.68 |
| August 20, 2026 | 3.57 |
| August 19, 2026 | 3.67 |
| August 18, 2026 | 3.52 |
| August 17, 2026 | 3.51 |
| August 14, 2026 | 3.44 |
| August 13, 2026 | 3.53 |
| August 12, 2026 | 3.14 |
| August 11, 2026 | 3.13 |
| August 10, 2026 | 3.12 |
| August 07, 2026 | 3.45 |
| August 06, 2026 | 3.22 |
| August 05, 2026 | 3.09 |
| August 04, 2026 | 2.985 |
| August 03, 2026 | 3.03 |
| July 31, 2026 | 2.97 |
| July 30, 2026 | 3.23 |
| July 29, 2026 | 3.49 |
| July 28, 2026 | 3.39 |
| July 27, 2026 | 3.38 |
| July 24, 2026 | 3.47 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Mirum Pharmaceuticals, Inc. | 82.93 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |